Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis

Introduction Porphyromonas gulae have the enzyme PPAD, as P. gingivalis , which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical oral investigations 2023-07, Vol.27 (7), p.3509-3519
Hauptverfasser: Castellar-Mendoza, Camilo, Castillo, Diana Marcela, Chila-Moreno, Lorena, Bautista-Molano, Wilson, Romero-Sánchez, Consuelo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3519
container_issue 7
container_start_page 3509
container_title Clinical oral investigations
container_volume 27
creator Castellar-Mendoza, Camilo
Castillo, Diana Marcela
Chila-Moreno, Lorena
Bautista-Molano, Wilson
Romero-Sánchez, Consuelo
description Introduction Porphyromonas gulae have the enzyme PPAD, as P. gingivalis , which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citrullinated proteins. There are no previous reports or studies investigating an association between P. gulae PPAD in rheumatoid arthritis (RA). Objective To assess the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PAD in patients with RA and their possible relationship with clinical activity markers. Subjects and methods A total of 95 patients with RA and 95 controls were included. Erythrocyte sedimentation rate (ESR), C-reactive protein, anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) were measured. Activity index-28 (DAS28) and SCDAI. The periodontal diagnosis was established. Presence of P. gulae and P. gingivalis . An ELISA was used to determine antibodies against citrullinated peptides of P. gulae PAD. Results A P. gulae frequency of 15.8% was observed in the RA group and 9.5% in the control group. Higher levels of ACPA were found in the P. gulae -positive patients of the RA group, finding no significant difference, but if in patients positive for P. gingivalis with statistical significance ( p = 0.0001). The frequency of anti-VDK-cit and anti-LPQ-cit9 antibodies to PPAD of P. gulae was higher in the RA group than in the control group without significant difference. No relationship was found with the clinical variables despite the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PPAD in patients with RA Conclusions It was not possible to establish a connection with clinical variables in RA and P. gulae ; as a result, the presence of P. gingivalis continues to contribute significantly to the increase in antibodies against citrullinated proteins/peptides from exogenous sources of citrullination in RA and periodontitis.
doi_str_mv 10.1007/s00784-023-04964-w
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10329627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2809002081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-7f8cd005cebfe6dc29dea4d7ec9171ac1242d9e2e3757bceb8b9c95bf433944f3</originalsourceid><addsrcrecordid>eNp9kU1PHSEUholpo9b2D7gwJN10My1fdxhWxljbmph4F3ZNGDhzL2YGrsBo_Pdir1rbhRs4yXnOCycPQoeUfKWEyG-5Hp1oCOMNEaoVzd0O2qeCtw2Xkr57Ve-hDzlfE0JFK_ku2uOSci4J2UdmGdNmfZ_iFIPJeDWPBrAJDi-XJ99rUXwfnYeMTQIcYsEJRlPA4RKx9SXN4-iDKT4G7ANOa5gnU6J3lS_r5IvPH9H7wYwZPj3dB-j3j7Or01_NxeXP89OTi8YK1pZGDp11hCws9AO0zjLlwAgnwSoqqbGUCeYUMOByIftKdb2yatEPgnMlxMAP0PE2dzP3EzgLoSQz6k3yk0n3Ohqv_-0Ev9areKsp4Uy1TNaEL08JKd7MkIuefLYwjiZAnLNmHVGEMNLRin7-D72Ocwp1v0pxseCdUKpSbEvZFHNOMLz8hhL9qFBvFeqqUP9RqO_q0NHrPV5Gnp1VgG-BXFthBenv22_EPgB7Tapm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2834538499</pqid></control><display><type>article</type><title>Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis</title><source>Springer Nature - Complete Springer Journals</source><creator>Castellar-Mendoza, Camilo ; Castillo, Diana Marcela ; Chila-Moreno, Lorena ; Bautista-Molano, Wilson ; Romero-Sánchez, Consuelo</creator><creatorcontrib>Castellar-Mendoza, Camilo ; Castillo, Diana Marcela ; Chila-Moreno, Lorena ; Bautista-Molano, Wilson ; Romero-Sánchez, Consuelo</creatorcontrib><description>Introduction Porphyromonas gulae have the enzyme PPAD, as P. gingivalis , which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citrullinated proteins. There are no previous reports or studies investigating an association between P. gulae PPAD in rheumatoid arthritis (RA). Objective To assess the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PAD in patients with RA and their possible relationship with clinical activity markers. Subjects and methods A total of 95 patients with RA and 95 controls were included. Erythrocyte sedimentation rate (ESR), C-reactive protein, anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) were measured. Activity index-28 (DAS28) and SCDAI. The periodontal diagnosis was established. Presence of P. gulae and P. gingivalis . An ELISA was used to determine antibodies against citrullinated peptides of P. gulae PAD. Results A P. gulae frequency of 15.8% was observed in the RA group and 9.5% in the control group. Higher levels of ACPA were found in the P. gulae -positive patients of the RA group, finding no significant difference, but if in patients positive for P. gingivalis with statistical significance ( p = 0.0001). The frequency of anti-VDK-cit and anti-LPQ-cit9 antibodies to PPAD of P. gulae was higher in the RA group than in the control group without significant difference. No relationship was found with the clinical variables despite the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PPAD in patients with RA Conclusions It was not possible to establish a connection with clinical variables in RA and P. gulae ; as a result, the presence of P. gingivalis continues to contribute significantly to the increase in antibodies against citrullinated proteins/peptides from exogenous sources of citrullination in RA and periodontitis.</description><identifier>ISSN: 1436-3771</identifier><identifier>ISSN: 1432-6981</identifier><identifier>EISSN: 1436-3771</identifier><identifier>DOI: 10.1007/s00784-023-04964-w</identifier><identifier>PMID: 37133700</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibodies ; C-reactive protein ; Citrulline ; Dental health ; Dentistry ; Diagnostic tests ; Enzyme-linked immunosorbent assay ; Erythrocyte sedimentation rate ; Gram-negative bacteria ; Gum disease ; Medicine ; Oral hygiene ; Pathophysiology ; Peptides ; Periodontics ; Periodontitis ; Porphyromonas ; Rheumatoid arthritis ; Rheumatoid factor</subject><ispartof>Clinical oral investigations, 2023-07, Vol.27 (7), p.3509-3519</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c426t-7f8cd005cebfe6dc29dea4d7ec9171ac1242d9e2e3757bceb8b9c95bf433944f3</cites><orcidid>0000-0002-1846-7448 ; 0000-0003-0684-9542 ; 0000-0002-1911-2892 ; 0000-0003-2811-0626 ; 0000-0002-6973-7639</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00784-023-04964-w$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00784-023-04964-w$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37133700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castellar-Mendoza, Camilo</creatorcontrib><creatorcontrib>Castillo, Diana Marcela</creatorcontrib><creatorcontrib>Chila-Moreno, Lorena</creatorcontrib><creatorcontrib>Bautista-Molano, Wilson</creatorcontrib><creatorcontrib>Romero-Sánchez, Consuelo</creatorcontrib><title>Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis</title><title>Clinical oral investigations</title><addtitle>Clin Oral Invest</addtitle><addtitle>Clin Oral Investig</addtitle><description>Introduction Porphyromonas gulae have the enzyme PPAD, as P. gingivalis , which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citrullinated proteins. There are no previous reports or studies investigating an association between P. gulae PPAD in rheumatoid arthritis (RA). Objective To assess the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PAD in patients with RA and their possible relationship with clinical activity markers. Subjects and methods A total of 95 patients with RA and 95 controls were included. Erythrocyte sedimentation rate (ESR), C-reactive protein, anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) were measured. Activity index-28 (DAS28) and SCDAI. The periodontal diagnosis was established. Presence of P. gulae and P. gingivalis . An ELISA was used to determine antibodies against citrullinated peptides of P. gulae PAD. Results A P. gulae frequency of 15.8% was observed in the RA group and 9.5% in the control group. Higher levels of ACPA were found in the P. gulae -positive patients of the RA group, finding no significant difference, but if in patients positive for P. gingivalis with statistical significance ( p = 0.0001). The frequency of anti-VDK-cit and anti-LPQ-cit9 antibodies to PPAD of P. gulae was higher in the RA group than in the control group without significant difference. No relationship was found with the clinical variables despite the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PPAD in patients with RA Conclusions It was not possible to establish a connection with clinical variables in RA and P. gulae ; as a result, the presence of P. gingivalis continues to contribute significantly to the increase in antibodies against citrullinated proteins/peptides from exogenous sources of citrullination in RA and periodontitis.</description><subject>Antibodies</subject><subject>C-reactive protein</subject><subject>Citrulline</subject><subject>Dental health</subject><subject>Dentistry</subject><subject>Diagnostic tests</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Erythrocyte sedimentation rate</subject><subject>Gram-negative bacteria</subject><subject>Gum disease</subject><subject>Medicine</subject><subject>Oral hygiene</subject><subject>Pathophysiology</subject><subject>Peptides</subject><subject>Periodontics</subject><subject>Periodontitis</subject><subject>Porphyromonas</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatoid factor</subject><issn>1436-3771</issn><issn>1432-6981</issn><issn>1436-3771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU1PHSEUholpo9b2D7gwJN10My1fdxhWxljbmph4F3ZNGDhzL2YGrsBo_Pdir1rbhRs4yXnOCycPQoeUfKWEyG-5Hp1oCOMNEaoVzd0O2qeCtw2Xkr57Ve-hDzlfE0JFK_ku2uOSci4J2UdmGdNmfZ_iFIPJeDWPBrAJDi-XJ99rUXwfnYeMTQIcYsEJRlPA4RKx9SXN4-iDKT4G7ANOa5gnU6J3lS_r5IvPH9H7wYwZPj3dB-j3j7Or01_NxeXP89OTi8YK1pZGDp11hCws9AO0zjLlwAgnwSoqqbGUCeYUMOByIftKdb2yatEPgnMlxMAP0PE2dzP3EzgLoSQz6k3yk0n3Ohqv_-0Ev9areKsp4Uy1TNaEL08JKd7MkIuefLYwjiZAnLNmHVGEMNLRin7-D72Ocwp1v0pxseCdUKpSbEvZFHNOMLz8hhL9qFBvFeqqUP9RqO_q0NHrPV5Gnp1VgG-BXFthBenv22_EPgB7Tapm</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Castellar-Mendoza, Camilo</creator><creator>Castillo, Diana Marcela</creator><creator>Chila-Moreno, Lorena</creator><creator>Bautista-Molano, Wilson</creator><creator>Romero-Sánchez, Consuelo</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1846-7448</orcidid><orcidid>https://orcid.org/0000-0003-0684-9542</orcidid><orcidid>https://orcid.org/0000-0002-1911-2892</orcidid><orcidid>https://orcid.org/0000-0003-2811-0626</orcidid><orcidid>https://orcid.org/0000-0002-6973-7639</orcidid></search><sort><creationdate>20230701</creationdate><title>Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis</title><author>Castellar-Mendoza, Camilo ; Castillo, Diana Marcela ; Chila-Moreno, Lorena ; Bautista-Molano, Wilson ; Romero-Sánchez, Consuelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-7f8cd005cebfe6dc29dea4d7ec9171ac1242d9e2e3757bceb8b9c95bf433944f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>C-reactive protein</topic><topic>Citrulline</topic><topic>Dental health</topic><topic>Dentistry</topic><topic>Diagnostic tests</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Erythrocyte sedimentation rate</topic><topic>Gram-negative bacteria</topic><topic>Gum disease</topic><topic>Medicine</topic><topic>Oral hygiene</topic><topic>Pathophysiology</topic><topic>Peptides</topic><topic>Periodontics</topic><topic>Periodontitis</topic><topic>Porphyromonas</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatoid factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castellar-Mendoza, Camilo</creatorcontrib><creatorcontrib>Castillo, Diana Marcela</creatorcontrib><creatorcontrib>Chila-Moreno, Lorena</creatorcontrib><creatorcontrib>Bautista-Molano, Wilson</creatorcontrib><creatorcontrib>Romero-Sánchez, Consuelo</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical oral investigations</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castellar-Mendoza, Camilo</au><au>Castillo, Diana Marcela</au><au>Chila-Moreno, Lorena</au><au>Bautista-Molano, Wilson</au><au>Romero-Sánchez, Consuelo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis</atitle><jtitle>Clinical oral investigations</jtitle><stitle>Clin Oral Invest</stitle><addtitle>Clin Oral Investig</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>27</volume><issue>7</issue><spage>3509</spage><epage>3519</epage><pages>3509-3519</pages><issn>1436-3771</issn><issn>1432-6981</issn><eissn>1436-3771</eissn><abstract>Introduction Porphyromonas gulae have the enzyme PPAD, as P. gingivalis , which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citrullinated proteins. There are no previous reports or studies investigating an association between P. gulae PPAD in rheumatoid arthritis (RA). Objective To assess the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PAD in patients with RA and their possible relationship with clinical activity markers. Subjects and methods A total of 95 patients with RA and 95 controls were included. Erythrocyte sedimentation rate (ESR), C-reactive protein, anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) were measured. Activity index-28 (DAS28) and SCDAI. The periodontal diagnosis was established. Presence of P. gulae and P. gingivalis . An ELISA was used to determine antibodies against citrullinated peptides of P. gulae PAD. Results A P. gulae frequency of 15.8% was observed in the RA group and 9.5% in the control group. Higher levels of ACPA were found in the P. gulae -positive patients of the RA group, finding no significant difference, but if in patients positive for P. gingivalis with statistical significance ( p = 0.0001). The frequency of anti-VDK-cit and anti-LPQ-cit9 antibodies to PPAD of P. gulae was higher in the RA group than in the control group without significant difference. No relationship was found with the clinical variables despite the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PPAD in patients with RA Conclusions It was not possible to establish a connection with clinical variables in RA and P. gulae ; as a result, the presence of P. gingivalis continues to contribute significantly to the increase in antibodies against citrullinated proteins/peptides from exogenous sources of citrullination in RA and periodontitis.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37133700</pmid><doi>10.1007/s00784-023-04964-w</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1846-7448</orcidid><orcidid>https://orcid.org/0000-0003-0684-9542</orcidid><orcidid>https://orcid.org/0000-0002-1911-2892</orcidid><orcidid>https://orcid.org/0000-0003-2811-0626</orcidid><orcidid>https://orcid.org/0000-0002-6973-7639</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1436-3771
ispartof Clinical oral investigations, 2023-07, Vol.27 (7), p.3509-3519
issn 1436-3771
1432-6981
1436-3771
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10329627
source Springer Nature - Complete Springer Journals
subjects Antibodies
C-reactive protein
Citrulline
Dental health
Dentistry
Diagnostic tests
Enzyme-linked immunosorbent assay
Erythrocyte sedimentation rate
Gram-negative bacteria
Gum disease
Medicine
Oral hygiene
Pathophysiology
Peptides
Periodontics
Periodontitis
Porphyromonas
Rheumatoid arthritis
Rheumatoid factor
title Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A56%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Porphyromonas%20gulae%20and%20PPAD%20antibodies%20are%20not%20related%20to%20citrullination%20in%20rheumatoid%20arthritis&rft.jtitle=Clinical%20oral%20investigations&rft.au=Castellar-Mendoza,%20Camilo&rft.date=2023-07-01&rft.volume=27&rft.issue=7&rft.spage=3509&rft.epage=3519&rft.pages=3509-3519&rft.issn=1436-3771&rft.eissn=1436-3771&rft_id=info:doi/10.1007/s00784-023-04964-w&rft_dat=%3Cproquest_pubme%3E2809002081%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2834538499&rft_id=info:pmid/37133700&rfr_iscdi=true